Express Scripts Canada’s Drug Evaluation Committee conducts monthly reviews of all new drugs that receive a Notice of Compliance from Health Canada to ascertain their place in therapy and assess the possible impact they will have on the private-payer sector. Published four times a year, Express Scripts Canada’s Health Newsflash newsletter summarizes such activity on a quarterly basis, offering health-benefits providers with comprehensive information about indications, dosages, therapeutic benefits, clinical implications, and pricing, as well as the potential role of each such drug in a prescription drug benefit program.